Safety and Efficacy of Direct Oral Anticoagulant Therapy in Patients With Cancer
Fovel LM, Seabury RW, Miller CD, Darko W, Probst LA, Horvath L.
J Pharm Pract. 2019 Dec 31:897190019896500. doi: 10.1177/0897190019896500. [Epub ahead of print]
CARDIONCOLOGY.ORG ABSTRACT:
This article compares the safety and efficacy of direct oral anticoagulants (DOAC) with low-molecular-weight heparin (LMWH) to prevent recurrent venous thromboembolism (VTE) in patients with cancer. Data from 156 patients indicated no difference in the frequency of VTE recurrence, suggesting DOAC may be an alternative to LMWH for the prevention of recurrent VTE in patients with cancer.
© All Rights Reserved